Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Hisashi, Nakayama"'
Autor:
Mitsuhiko Moriyama, Tatsuo Kanda, Yutaka Midorikawa, Hiroshi Matsumura, Ryota Masuzaki, Hitomi Nakamura, Masahiro Ogawa, Shunichi Matsuoka, Toshikatu Shibata, Motomi Yamazaki, Kazumichi Kuroda, Hisashi Nakayama, Tokio Higaki, Kazunori Kanemaru, Toshio Miki, Masahiko Sugitani, Tadatoshi Takayama
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-21 (2022)
Abstract Recently, we reported that extent of proliferation of atypical hepatocytes (atypical hepatocytes) was most important histological risk factor for development of hepatocellular carcinoma (HCC) from chronic hepatitis C or liver cirrhosis. Here
Externí odkaz:
https://doaj.org/article/27e6f2d8468c4fb0b2d055a0dbb1b956
Autor:
Tadatoshi Takayama, Kiyoshi Hasegawa, Namiki Izumi, Masatoshi Kudo, Mitsuo Shimada, Naoki Yamanaka, Masafumi Inomata, Shuichi Kaneko, Hisashi Nakayama, Yoshikuni Kawaguchi, Kosuke Kashiwabara, Ryosuke Tateishi, Shuichiro Shiina, Kazuhiko Koike, Yutaka Matsuyama, Masao Omata, Masatoshi Makuuchi, Norihiro Kokudo
Publikováno v:
Liver Cancer (2021)
Introduction: It remains unclear which of surgery or radiofrequency ablation (RFA) is the more effective treatment for small hepatocellular carcinoma (HCC). We aimed to compare survival between patients undergoing surgery (surgery group) and patients
Externí odkaz:
https://doaj.org/article/03fda64c54cd487eb1826d59971f3ba0
Autor:
Peipei Song, Yutaka Midorikawa, Hisashi Nakayama, Tokio Higaki, Masamichi Moriguchi, Osamu Aramaki, Shintaro Yamazaki, Masaru Aoki, Kenichi Teramoto, Tadatoshi Takayama
Publikováno v:
Cancer Medicine, Vol 8, Iss 13, Pp 5862-5871 (2019)
Abstract Combined hepatocellular‐cholangiocarcinoma (cHCC‐CC) and intrahepatic cholangiocarcinoma (ICC) are classified into one category, but comparison of prognosis of the two carcinomas remains controversial. The aim of the current study was to
Externí odkaz:
https://doaj.org/article/264ab24e4b6e40e5ba289c16eea618af
Autor:
Yutaka Midorikawa, Tadatoshi Takayama, Hisashi Nakayama, Tokio Higaki, Masamichi Moriguchi, Kyoji Moriya, Tatsuo Kanda, Shunichi Matsuoka, Mitsuhiko Moriyama
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Prior hepatitis B virus infection (PBI) may increase the risk of developing hepatocellular carcinoma (HCC), but the impact of PBI on clinical outcomes following treatment for HCC remains unknown. The aim of this study was to clari
Externí odkaz:
https://doaj.org/article/b557d7695cce46f680249677bc49503a
Autor:
Takehito Otsubo, Shinjiro Kobayashi, Keiji Sano, Takeyuki Misawa, Satoshi Katagiri, Hisashi Nakayama, Shuji Suzuki, Manabu Watanabe, Shunichi Ariizumi, Michiaki Unno, Minoru Tanabe, Hiroaki Nagano, Norihiro Kokudo, Satoshi Hirano, Masafumi Nakamura, Ken Shirabe, Yasuyuki Suzuki, Masahiro Yoshida, Yasutsugu Takada, Toshio Nakagohri, Akihiko Horiguchi, Hideki Ohdan, Susumu Eguchi, Masayuki Ohtsuka, Masayuki Sho, Toshiki Rikiyama, Etsuro Hatano, Akinobu Taketomi, Tsutomu Fujii, Hiroki Yamaue, Masaru Miyazaki, Masakazu Yamamoto, Tadahiro Takada, Itaru Endo
Publikováno v:
Journal of Hepato-Biliary-Pancreatic Sciences. 30:60-71
To ensure that highly advanced hepatobiliary-pancreatic surgery (HBPS) is performed safely, the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS) board certification system for expert surgeons established a safety committee to monitor su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d81ea9a4df1dfee6a81030338c99c0b
https://doi.org/10.1002/jhbp.1186
https://doi.org/10.1002/jhbp.1186
Autor:
Nao, Yoshida, Yutaka, Midorikawa, Tokio, Higaki, Hisashi, Nakayama, Masamichi, Moriguchi, Osamu, Aramaki, Shingo, Tsuji, Yukiyasu, Okamura, Tadatoshi, Takayama
Publikováno v:
World Journal of Surgery. 46:1134-1140
We aimed to validate our algorithm for resecting Hepatocellular carcinoma (HCC) in the caudate lobe based on tumor location, tumor size, and indocyanine green clearance rate.Patients who underwent curative resections for solitary HCC in the caudate l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ebda876cb68a7487f848af5dc14dd1
https://doi.org/10.1007/s00268-022-06453-9
https://doi.org/10.1007/s00268-022-06453-9
Autor:
Susumu Mochizuki, Osamu Aramaki, Tokio Higaki, Tadatoshi Takayama, Hisashi Nakayama, Masamichi Moriguchi, Yutaka Midorikawa
Publikováno v:
International Surgery. 105:743-752
Objective The effect of postoperative complications including red blood cell transfusion (BT) on long-term survival for hepatocellular carcinoma (HCC) is unknown. The purpose of this study was to define the relationship between postoperative complica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::517e654ab91b244730aab7851c951a58
https://doi.org/10.9738/intsurg-d-21-00010.1
https://doi.org/10.9738/intsurg-d-21-00010.1
Publikováno v:
Journal of gastroenterology.
Hepatectomy, the most common treatment for hepatocellular carcinoma, is associated with greater intraoperative blood loss than is resection of other malignancies. The effect of blood product transfusion (red blood cell [RBC], platelet, fresh frozen p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7854238f546ff6d46113515ad02d2656
https://pubmed.ncbi.nlm.nih.gov/36592217
https://pubmed.ncbi.nlm.nih.gov/36592217
Autor:
Hisashi Nakayama, Yukiyasu Okamura, Susumu Mochizuki, Akihisa Hojo, Masamichi Moriguchi, Tokio Higaki, Tadatoshi Takayama, Arata Tsukamoto, Akiyoshi Itoh
Aims: We aimed to develop a computer-assisted system for the gross classification of resected hepatocellular carcinoma (HCC) and to evaluate whether this objective classification can be used to predict patient outcomes.Methods: This study included 23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea221341840a024fa7cc393d4893def6
https://doi.org/10.21203/rs.3.rs-1570299/v1
https://doi.org/10.21203/rs.3.rs-1570299/v1
Autor:
Naoki Yoshida, Yutaka Midorikawa, Takahiro Kajiwara, Nao Yoshida, Hisashi Nakayama, Masahiko Sugitani, Tadatoshi Takayama
Publikováno v:
Case Reports in Gastroenterology, Vol 7, Iss 1, Pp 169-174 (2013)
Hepatocellular carcinoma (HCC) with sarcomatoid change is a rare neoplasm of the liver, and recurrent therapies for HCC such as transcatheter arterial chemoembolization and percutaneous ablation therapy are presumed to promote sarcomatoid change. A 7
Externí odkaz:
https://doaj.org/article/472c45e0ef8d41109b47e00862c51097